[Systemic enzymotherapy as a method of prophylaxis of postradiation complications in oncological patients].
Set out in the paper are results of treatment of those patients with carcinoma of the lung, uterine cervix, hysterocarcinoma, breast cancer, malignant thymomas, malignant non-Hodgkin's lymphomas, and lymphogranulematosis having been administered combined, chemoradiation or radiation treatments against the background of a complex of accompanying therapy involving systemic enzymotherapy. Polyenzymic drugs were found to be capable of improving results of treatment of acute radiation reactions and preventing postradiation fibrous changes in the lungs, skin, fatty tissue, soft tissue, liver, kidneys. Thus, systemic enzymotherapy is capable of improving the quality of life and results of treatment of oncological patients.
Hubarieva
H O
HO
Kindzel's'kyĭ
L P
LP
Ponomar'ova
O V
OV
Udatova
T V
TV
Shpil'ova
S I
SI
Smolanka
I I
II
Korovin
S I
SI
Ivankin
V S
VS
D000293:Adolescent; D000328:Adult; D000368:Aged; D001963:Bromelains / Q000008:administration & dosage / Q000627:therapeutic use*; D002918:Chymotrypsin / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006867:Hydrolases / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000532:radiotherapy*; D010206:Papain / Q000008:administration & dosage / Q000627:therapeutic use*; D011832:Radiation Injuries / Q000517:prevention & control*; D011878:Radiotherapy / Q000009:adverse effects; D012431:Rutin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome; D014357:Trypsin / Q000008:administration & dosage / Q000627:therapeutic use*
D004338:Drug Combinations; C119937:Phlogenzym; D012431:Rutin; C009685:chymotrypsin, papain, trypsin drug combination; C023295:Wobenzym; D001963:Bromelains; D006867:Hydrolases; D002918:Chymotrypsin; D014357:Trypsin; D010206:Papain